site stats

Attrax putty nuvasive

WebMar 5, 2024 · – Attrax Putty is now the first and only ceramic bone graft substitute supported by Level I evidence to demonstrate non-inferior fusion performance compared to autograft 1 –. SAN DIEGO – March 5, 2024 – NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally … WebFeb 21, 2024 · NuVasive’s Attrax Putty received FDA clearance for use in thoracolumbar interbody fusion spacers last year. In doing so, it became the first synthetic bone graft substitute to receive such ...

FDA clears expanded use for NuVasive C360 portfolio

WebJan 10, 2024 · NuVasive, Inc. NUVA recently announced the receipt of the FDA 510(k) approval for expanded indications of use for Attrax Putty, with its wide-ranging … WebJan 10, 2024 · NuVasive, Inc. NUVA recently announced the receipt of the FDA 510(k) approval for expanded indications of use for Attrax Putty, with its wide-ranging thoracolumbar interbody portfolio for spine ... make waves with keyboard symbols https://lixingprint.com

Clinical Study Validates NuVasive Porous Interbody Implant and ...

WebJan 10, 2024 · NuVasive's (NUVA) Attrax Putty is the first and only synthetic biologic to receive 510(k) indications for use in interbody fusions of the thoracolumbar spine. WebAttrax Attrax is a unique synthetic, bioactive, and osteoconductive, bone void filler designed to drive bone fusion. Attrax Putty is the first and only … WebAttrax® Attrax is a unique ceramic bone graft substitute with an optimized surface microarchitecture designed to drive bone fusion. Attrax Putty is the first and only ceramic supported by a Level I randomized controlled trial as a bone graft substitute in posterolateral lumbar fusions (PLF). 1 The proof is in the putty. make waves vbs decorations

NuVasive (NUVA) Gets FDA Nod for Attrax Putty Expanded Use

Category:Attrax—The Proof is in the Putty – NuVasive

Tags:Attrax putty nuvasive

Attrax putty nuvasive

Randomized Controlled Trial Results Published in

WebFeb 21, 2024 · Attrax Putty is now on-label for use with cervical Modulus interbody implants. SAN DIEGO, Feb. 21, 2024 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation ... Web"A study of this quality immediately differentiates Attrax Putty from other biologics on the market," said Matt Link, president of NuVasive."Attrax has proven the critical role surface optimization plays in the effectiveness of bone grafting technology, and underscores the NuVasive approach to developing innovative solutions which deliver positive clinical …

Attrax putty nuvasive

Did you know?

WebThe publication of these results further reinforces NuVasive’s position as a leader in the spine market, offering innovative solutions to support positive clinical outcomes. Attrax … WebSep 26, 2014 · Official Title: AttraX® Putty vs. Autograft in eXtreme Lateral Interbody Fusion (XLIF®): A Prospective Randomized Single-Center Evaluation of Radiographic and Clinical Outcomes. Actual Study Start Date : December 2014. Actual Primary Completion Date : May 21, 2024. Actual Study Completion Date : May 21, 2024.

WebThe publication of these results further reinforces NuVasive’s position as a leader in the spine market, offering innovative solutions to support positive clinical outcomes. Attrax … WebFeb 21, 2024 · Attrax Putty is now on-label for use with cervical Modulus interbody implants SAN DIEGO, Feb. 21, 2024 /PRNewswire/ -- NuVasive, Inc. (NASDAQ:NUVA), the leader in spine technology innovation ...

WebSep 26, 2014 · Official Title: AttraX® Putty vs. Autograft in eXtreme Lateral Interbody Fusion (XLIF®): A Prospective Randomized Single-Center Evaluation of Radiographic … WebFeb 21, 2024 · Attrax Putty is now on-label for use with cervical Modulus interbody implants. SAN DIEGO, Feb. 21, 2024 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that it received …

WebFeb 28, 2024 · February 28, 2024. The FDA has cleared an expanded indication of a combination of NuVasive’s Modulus Cervical interbody implant with Attrax Putty bone void filler. Attrax Putty is the first synthetic bone graft substitute to receive FDA clearance for use in thoracolumbar interbody fusion spacers. The devices are part of the company’s C360 ...

WebNov 13, 2013 · This product is AttraX® Putty (CE-557130), a bioresorbable tricalcium phosphate (TCP), mixed with a fast resorbing polymer carrier to improve surgical handling. The aim of the current study is to clinically investigate AttraX® Putty as an alternative to autologous bone graft in adult patients qualified for instrumented posterolateral fusion ... make wax candles scentedWebOct 3, 2024 · NuVasive AttraX Putty. is a synthetic, osteoconductive and resorbable bone void filler device consisting of ceramic granules premixed with a polymeric binder that provides cohesion between the granules. Pressure applied by user manipulation allows the AttraX Putty to be molded into specific shapes, mixed with autograft, or contoured into a … make wax melter sculpey clayWebMar 10, 2024 · Supported by the results of this study, NuVasive received U.S. Food and Drug Administration (FDA) 510 (k) clearance for expanded use of Attrax Putty without … make waxing near memake wax melts in plastic moldsWebJan 5, 2024 · The NuVasive Attrax Putty is a synthetic, bioactive and osteoconductive bone void filler designed to drive bone fusion. This proprietary, advanced biomaterial … make waxing less painfulWebJul 2, 2024 · San Diego, California-based NuVasive, Inc. has announced the U.S. launch of AttraX Scaffold, the company’s absorbent ceramic-collagen bone graft with an optimized surface. ... AttraX Scaffold … make wax melts from old candlesWebNuvasive Inc: 03/20/2024: 7:00AM: PR Newswire (US) NuVasive Specialized Orthopedics Expands Indications of Precice Limb Lengthening System to Treat Pediatric Patients: NASDAQ:NUVA: Nuvasive Inc ... make wax with butane propane miv